Literature DB >> 26032985

Campaigners challenge patent applications for hepatitis C drug in five countries.

Sanjeet Bagcchi1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26032985     DOI： 10.1136/bmj.h2938

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation.

Authors:  Giovanni Cenderello; Stefania Artioli; Claudio Viscoli; Ambra Pasa; Mauro Giacomini; Barbara Giannini; Chiara Dentone; Laura Ambra Nicolini; Giovanni Cassola; Antonio Di Biagio
Journal:  Clinicoecon Outcomes Res       Date:  2015-12-31

2.  Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.

Authors:  Céline Grillon; Priti R Krishtel; Othoman Mellouk; Anton Basenko; James Freeman; Luís Mendão; Isabelle Andrieux-Meyer; Sébastien Morin
Journal:  J Int AIDS Soc       Date:  2018-04       Impact factor: 5.396
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.